Načítá se...
Spotlight on the Low dose Rosiglitazone/ Metformin Combination In Prevention of Type 2 Diabetes
Diabetes mellitus is one of the major challenges to public health with global prevalence of 6.6% (285 million) and annual cost of 376 billion US dollars. Pharmacological and non pharmacological interventions which target either to delay the onset of diabetes or to prevent its complications have been...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Archives of Global Professionals
2010-10-01
|
| Edice: | Archives of Pharmacy Practice |
| Témata: | |
| On-line přístup: | http://www.archivepp.com/Resources/Files/22102010104335868.pdf |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|